What is the workup for hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hypercalcemia

The diagnostic workup for hypercalcemia should include serum calcium, albumin, intact parathyroid hormone (iPTH), parathyroid hormone-related protein (PTHrP), 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, serum phosphorus, magnesium, blood urea nitrogen, and creatinine to determine the underlying cause and guide appropriate treatment. 1

Initial Assessment

  • Classify severity of hypercalcemia as mild (>5.0 to <5.5 mEq/L), moderate (5.5 to 6.0 mEq/L), or severe (>6.0 mEq/L or >14.0 mg/dL) 1
  • Evaluate for symptoms based on severity and acuity of onset:
    • Mild/moderate: polyuria, polydipsia, nausea, constipation, fatigue, vomiting, abdominal pain, myalgia 1, 2
    • Severe: mental status changes, bradycardia, hypotension, dehydration, acute renal failure 1, 2

Diagnostic Algorithm

First-Line Laboratory Tests

  • Serum calcium (total and ionized) 1
  • Albumin (for corrected calcium calculation) 1
  • Intact parathyroid hormone (iPTH) - most important initial test to distinguish PTH-dependent from PTH-independent causes 1, 2
  • Serum creatinine and blood urea nitrogen 1
  • Serum phosphorus and magnesium 1

Second-Line Laboratory Tests (Based on Initial Results)

  • If PTH is elevated or inappropriately normal with hypercalcemia:

    • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels 1
    • Urine calcium/creatinine ratio to evaluate for hypercalciuria 1
    • Consider familial hypocalciuric hypercalcemia if urine calcium is low 2
  • If PTH is suppressed (<20 pg/mL):

    • Parathyroid hormone-related protein (PTHrP) 1
    • 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels 1
    • Consider malignancy workup (chest X-ray, mammogram, serum/urine protein electrophoresis) 2, 3
    • Consider medication review for calcium-raising drugs (thiazides, lithium, vitamin A, vitamin D supplements) 2

Additional Tests Based on Clinical Suspicion

  • Renal ultrasonography if hypercalciuria is present to evaluate for nephrocalcinosis 1
  • Serum angiotensin-converting enzyme (ACE) and chest imaging if granulomatous disease is suspected 3
  • Thyroid function tests to rule out hyperthyroidism 2

Interpretation of Results

  • Primary hyperparathyroidism: elevated or inappropriately normal PTH, mild hypercalcemia (<12 mg/dL), chronic course (>6 months), possible kidney stones, hyperchloremic metabolic acidosis 2, 3
  • Malignancy: suppressed PTH, rapidly progressive hypercalcemia, higher calcium levels, anemia, no kidney stones or metabolic acidosis 3
  • Vitamin D intoxication: suppressed PTH, elevated 25-hydroxyvitamin D 2
  • Granulomatous disorders: suppressed PTH, elevated 1,25-dihydroxyvitamin D, normal 25-hydroxyvitamin D 2, 3

Common Pitfalls and Caveats

  • Always correct calcium for albumin when using total calcium measurements 1, 2
  • Mild hypercalcemia (serum calcium <12 mg/dL) is most commonly due to primary hyperparathyroidism, while severe hypercalcemia is more often associated with malignancy 2, 3
  • Medications that can cause hypercalcemia include thiazide diuretics, lithium, vitamin A, vitamin D supplements, calcium supplements, and some newer agents like SGLT2 inhibitors 2
  • Hypercalcemia of malignancy can occur even without bone metastases due to PTHrP production 4
  • In patients with kidney disease, interpret PTH levels with caution as secondary hyperparathyroidism can coexist with other causes of hypercalcemia 5

Special Considerations

  • In children with Williams syndrome, monitor calcium levels every 4-6 months until 2 years of age, then every 2 years thereafter 5
  • For pediatric patients with hypercalcemia, check serum blood urea nitrogen, creatinine, vitamin D concentrations (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D), and intact parathyroid hormone 5
  • In dialysis patients, consider dialysate calcium concentration adjustments based on PTH levels and bone disease status 5

By systematically following this diagnostic approach, the underlying cause of hypercalcemia can be identified, allowing for appropriate targeted treatment to reduce morbidity and mortality associated with this condition.

References

Guideline

Approach to Evaluating Hypercalcemia in an Outpatient Setting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

Hypercalcemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2009

Research

Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

North American journal of medical sciences, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.